Can the Polynovo (ASX:PNV) share price hit $3 by Christmas?

The broker Macquarie thinks that Polynovo shares are going to be heading higher.
The post Can the Polynovo (ASX:PNV) share price hit $3 by Christmas? appeared first on The Motley Fool Australia. –

Is it possible that the Polynovo Ltd (ASX: PNV) share price could rise to $3 by Christmas?

One broker thinks that the healthcare business could rise by more than 50%.

But how quickly could that return come? An early Christmas present?

Brokers have price targets on a wide array of businesses. That’s where the analysts believe that the shares prices could be in 12 months from now. Whilst it’s possible that shares can move in shorter-term timeframes, the broker’s latest price target on Polynovo is referring to where it will be in the latter stages of 2022.

What is the price target on the Polynovo share price?

The brokers at Macquarie Group Ltd (ASX: MQG) have a price target on Polynovo of $2.85, which is not far off $3. Macquarie rates Polynovo shares as a buy.

Macquarie thinks that the business has a good future with hopes of pleasing growth in the coming years, though FY22 may not be as good because of the ongoing impact of the COVID-19 pandemic on the company. It was the FY22 first quarter update that gave the broker food for thought.

First quarter update

The managing director of Polynovo, Paul Brennan, said:

A strong start to the first quarter of FY22 follows the strong fourth quarter finish in FY21 despite continuing COVID restriction in the southern States of the US. Our teams are expanding and signing new accounts and as patient access improves, we expect this will translate into strong sales.

The business reported a COVID-impacted performance in Australia, New Zealand and the US.

Here in the ANZ market, it said that Australia and New Zealand results were impacted by the extended hard lockdowns in New South Wales and Victoria. It’s expecting sales to improve in the second quarter as COVID restrictions reduce. The company said that new accounts in its direct markets (excluding distributor markets) in the first quarter of FY22 were up 56% year on year.

The company had the most positive comments about the European section of the business.

It noted that face to face meetings are back, conferences are being attended and hospital access has returned to near normal levels. It’s expecting to sign new distributors in the second quarter of FY22, including Cyprus and the Czech Republic. Other jurisdictions such as France and Portugal are in negotiation.

Polynovo said that the EU performed well with growth of 204% in the first quarter.

A new third-party distribution centre in Belgium is operational and filling sales orders with deliveries to Germany, Finland and an order from Italy being filled this week. The company also said that there are indications that orders will commence soon to other distributors in Poland, Turkey and Greece.

Finally, Polynovo said that the relaxation of COVID restrictions in the UK and Irish hospitals has been positive for the business, whilst also being helped by some clinical trials. First quarter sales were up 327% on the same quarter last year.

What is the Polynovo share price valuation?

Macquarie thinks that Polynovo could generate 2.5 cents of earnings per share (EPS) in FY23, translating to a price/earnings ratio of 73 for FY23.

The post Can the Polynovo (ASX:PNV) share price hit $3 by Christmas? appeared first on The Motley Fool Australia.

Should you invest $1,000 in Polynovo right now?

Before you consider Polynovo, you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Polynovo wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

More reading

Polynovo (ASX:PNV) share price rises after “positive” FY22 quarterly update

Why is the Polynovo (ASX:PNV) share price having such a tough time of late?

3 ASX 200 shares down more than 50% in 2021

Why these 3 ASX shares all hit 52-week lows today

Why has the Polynovo (ASX:PNV) share price tanked 15% in 3 weeks?

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended POLYNOVO FPO. The Motley Fool Australia owns shares of and has recommended Macquarie Group Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!